PCVX
#890
Vaxcyte, Inc. - Common Stock
68.3 0 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.25%
Changement Mensuel
+14.41%
Evolution sur 6 mois
+8.83%
Changement Annuel
+61.47%
Clôture Précédente
66.8 0
Open
66.6 9
Low
66.2 1
High
69.2 1
Financials
- Market Capitalization 10.16 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.vaxcyte.com
- Headquarter Delaware, United States
- FIGI BBG009PHHPL8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.2
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 873 |  IBRX ImmunityBio, Inc. - Common Stock | 10.28 USD | +4.90% | +6.53% | +23.56% | +309.56% | 10.90 B USD | ||
| 887 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.11 USD | +0.74% | +1.27% | +3.47% | +99.55% | 10.06 B USD | ||
| 911 |  KRYS Krystal Biotech, Inc. - Common Stock | 329.31 USD | +2.54% | +1.79% | -2.86% | +75.98% | 9.75 B USD | ||
| 939 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.91 USD | -1.14% | -3.98% | -7.17% | +82.23% | 8.86 B USD |